G1 Therapeutics
Founded in 2008, G1 Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development, and delivery of therapies that improve the lives of those affected by cancer. The company's headquartered in Research Triangle Park, North Carolina.
Last updated on
About G1 Therapeutics
Founded
2012Estimated Revenue
$10M-$50MEmployees
51-250Funding / Mkt. Cap
$206MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
28NAICs Code
541Location
City
DurhamState
North CarolinaCountry
United StatesTech Stack (31)
